These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 4308378

  • 21. An assessment of 5'-nucleotidase as a liver-function test.
    Hill PG, Sammons HG.
    Q J Med; 1967 Oct; 36(144):457-68. PubMed ID: 6077226
    [No Abstract] [Full Text] [Related]

  • 22. [Behavior of the serum electrolytes sodium and potassium in patients with cholelithiasis with reference to pathologic changes in the liver].
    Schmauss AK, Gerloff D, Poley FW.
    Z Gesamte Inn Med; 1971 May 15; 26(10):327-31. PubMed ID: 5131401
    [No Abstract] [Full Text] [Related]

  • 23. [Combined determination of total alkaline phosphatases and 5-nucleotidase in bone pathology].
    Lejeune E, Bouvier M, Ruitton P, Queneau P, Lambert, Flechaire A.
    Rev Rhum Mal Osteoartic; 1973 Oct 15; 40(10):573-80. PubMed ID: 4767881
    [No Abstract] [Full Text] [Related]

  • 24. [On serum bile acids].
    Mashimo K, Nakagawa S, Ishiya T, Makino I.
    Saishin Igaku; 1969 Mar 15; 24(3):615-27. PubMed ID: 4890894
    [No Abstract] [Full Text] [Related]

  • 25. [Hemostasis disorders in liver diseases].
    Rosiek B.
    Pol Tyg Lek; 1974 Jun 15; 29(25):1097-100. PubMed ID: 4601905
    [No Abstract] [Full Text] [Related]

  • 26. Serum magnesium in hepatic disorders.
    Nath K, Sur BK, Gupta BK, Mital HS, Seth ON.
    J Assoc Physicians India; 1969 Jun 15; 17(6):349-51. PubMed ID: 5347670
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical significance of the determination of bilirubin fractions in some liver diseases].
    Guseva TM, Rozanova LB, Semendiaeva ME, Tareeva IE.
    Sov Med; 1968 Jul 15; 31(7):52-7. PubMed ID: 5741648
    [No Abstract] [Full Text] [Related]

  • 28. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H, Beppu T, Seyama Y, Wada T.
    Gastroenterol Jpn; 1983 Jun 15; 18(3):246-51. PubMed ID: 6307803
    [Abstract] [Full Text] [Related]

  • 29. [Importance of determination of the activity of alkaline phosphatase of blood serum in differentiation of parenchymatous and obstructive jaundice].
    BLIUGER AF.
    Sov Med; 1957 Dec 15; 21(12):78-83. PubMed ID: 13529323
    [No Abstract] [Full Text] [Related]

  • 30. Clinical usefulness of serum cholylglycine determination in various liver diseases.
    Tanggo Y, Fujiyama S, Kin F, Tashiro A, Shiraoku H, Akahoshi M, Sato Y, Hashiguchi O, Sagara K.
    Gastroenterol Jpn; 1982 Oct 15; 17(5):447-52. PubMed ID: 7173571
    [Abstract] [Full Text] [Related]

  • 31. [Behavior of serum bilirubin and serum enzymes in acute viral hepatitis during therapy with Reducdyn].
    SCHOLTHOLT J.
    Ther Ggw; 1962 Jun 15; 101():264-7. PubMed ID: 13909149
    [No Abstract] [Full Text] [Related]

  • 32. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease.
    Tăpălagă D, Opincaru A, Cucuianu M.
    Acta Hepatogastroenterol (Stuttg); 1979 Feb 15; 26(1):9-16. PubMed ID: 34311
    [No Abstract] [Full Text] [Related]

  • 33. [A new test for dysproteinemia: the chlorogenic acid tests. II. Application to serums of patients having liver dysfunction].
    Tayeau F, Traissac FJ, Marquevielle J, Séchet J, Duhamel-Reiss A, Gratadour J.
    Ann Biol Clin (Paris); 1968 Feb 15; 26(10):1193-201. PubMed ID: 5303987
    [No Abstract] [Full Text] [Related]

  • 34. [Plasmatic angiotensinase activity in subjects with hepatic diseases of various types].
    Morandini G, Dimich D, Manca P, Spanedda M.
    Minerva Med; 1967 May 19; 58(40):1876-81. PubMed ID: 4290743
    [No Abstract] [Full Text] [Related]

  • 35. Liver diseases and cancer associated with lack of lymphocytic cortisol metabolism enhancing factor.
    Klein A, Barkan E, Barkan A, Hoogervorst-Spalter H, Arie R, Kaufmann H.
    Metabolism; 1980 Aug 19; 29(8):780-6. PubMed ID: 7402079
    [No Abstract] [Full Text] [Related]

  • 36. [Semiautomatic method of measurement of serum 5'nucleotidase activity].
    Hennon G, Plaquet R.
    Ann Biol Clin (Paris); 1975 Aug 19; 33(1):21-8. PubMed ID: 242242
    [Abstract] [Full Text] [Related]

  • 37. Serum desialylated glycoproteins in patients with hepatobiliary dysfunction.
    Marshall JS, Williams S, Jones P, Hepner GW.
    J Lab Clin Med; 1978 Jul 19; 92(1):30-7. PubMed ID: 96195
    [No Abstract] [Full Text] [Related]

  • 38. [ -Fetoprotein in liver diseases and extrahepatic tumors. Case review].
    Cavallero F, Cheli R.
    Minerva Med; 1972 Jun 09; 63(44):2475-7. PubMed ID: 4338453
    [No Abstract] [Full Text] [Related]

  • 39. [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
    Erb W, Schreiber J, Walczak M.
    Z Gastroenterol; 1973 May 09; 11(4):279-88. PubMed ID: 4803425
    [No Abstract] [Full Text] [Related]

  • 40. [Reaction of fractionated bilirubin in blood & of alkaline phosphatase in acute hepatitis treated with prednisone & ACTH].
    PICCHIO E, ROTTINI E.
    Riforma Med; 1958 Jan 18; 72(3):61-4. PubMed ID: 13528599
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.